IL309883A - Use of lactobacillus paracasei bacterial strains in the treatment of newborns - Google Patents
Use of lactobacillus paracasei bacterial strains in the treatment of newbornsInfo
- Publication number
- IL309883A IL309883A IL309883A IL30988324A IL309883A IL 309883 A IL309883 A IL 309883A IL 309883 A IL309883 A IL 309883A IL 30988324 A IL30988324 A IL 30988324A IL 309883 A IL309883 A IL 309883A
- Authority
- IL
- Israel
- Prior art keywords
- group
- alternatively
- strain
- mixture
- bacteria
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102021000018740A IT202100018740A1 (it) | 2021-07-15 | 2021-07-15 | Uso di ceppi di batteri Lactobacillus paracasei nel trattamento di neonati |
| PCT/IB2022/056538 WO2023286027A1 (en) | 2021-07-15 | 2022-07-15 | Use of lactobacillus paracasei bacterial strains in the treatment of newborns |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL309883A true IL309883A (en) | 2024-03-01 |
Family
ID=78212428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL309883A IL309883A (en) | 2021-07-15 | 2022-07-15 | Use of lactobacillus paracasei bacterial strains in the treatment of newborns |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240350567A1 (https=) |
| EP (1) | EP4370142A1 (https=) |
| JP (1) | JP2024525794A (https=) |
| KR (1) | KR20240038015A (https=) |
| CN (1) | CN119365205A (https=) |
| AU (1) | AU2022312760A1 (https=) |
| CA (1) | CA3222905A1 (https=) |
| IL (1) | IL309883A (https=) |
| IT (1) | IT202100018740A1 (https=) |
| MX (1) | MX2024000520A (https=) |
| WO (1) | WO2023286027A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118813489A (zh) * | 2024-08-29 | 2024-10-22 | 北京科拓恒通生物技术股份有限公司 | 一种用于缓解便秘和腹泻的益生菌后生元和制备方法及其用途 |
| CN120361059A (zh) * | 2025-06-30 | 2025-07-25 | 天津创源生物技术有限公司 | 一种副干酪乳酪杆菌iob413后生元在胃食管反流上的应用 |
| CN121533530A (zh) * | 2026-01-19 | 2026-02-17 | 内蒙古农业大学 | 一种副干酪乳酪杆菌-复合益生元复配制剂、制备方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8784798B2 (en) * | 2009-05-11 | 2014-07-22 | Nestec S.A. | Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders |
| IT201900000801A1 (it) * | 2019-01-18 | 2020-07-18 | Proge Farm Srl | Composizione comprendente batteri probiotici non vitali e suo uso in terapia |
| IT201900016865A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Composizioni a base di ceppi batterici e loro uso come antinfiammatori |
| IT201900016811A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali |
| IT201900020422A1 (it) * | 2019-11-05 | 2021-05-05 | Sofar Spa | Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine |
| IT202000012448A1 (it) * | 2020-05-26 | 2021-11-26 | Sofar Spa | Composizioni comprendenti un derivato della cannabis sativa e ceppi di batteri e loro uso terapeutico |
| IT202100008300A1 (it) * | 2021-04-01 | 2022-10-01 | Bll Invest S R L | Ceppi di batteri inattivati, quali batteri vitali ma non coltivabili, loro composizioni e loro uso |
-
2021
- 2021-07-15 IT IT102021000018740A patent/IT202100018740A1/it unknown
-
2022
- 2022-07-15 EP EP22751158.1A patent/EP4370142A1/en active Pending
- 2022-07-15 WO PCT/IB2022/056538 patent/WO2023286027A1/en not_active Ceased
- 2022-07-15 IL IL309883A patent/IL309883A/en unknown
- 2022-07-15 US US18/579,158 patent/US20240350567A1/en active Pending
- 2022-07-15 CN CN202280049761.9A patent/CN119365205A/zh active Pending
- 2022-07-15 KR KR1020247005329A patent/KR20240038015A/ko active Pending
- 2022-07-15 MX MX2024000520A patent/MX2024000520A/es unknown
- 2022-07-15 AU AU2022312760A patent/AU2022312760A1/en active Pending
- 2022-07-15 JP JP2024502018A patent/JP2024525794A/ja active Pending
- 2022-07-15 CA CA3222905A patent/CA3222905A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022312760A1 (en) | 2024-02-22 |
| US20240350567A1 (en) | 2024-10-24 |
| WO2023286027A1 (en) | 2023-01-19 |
| KR20240038015A (ko) | 2024-03-22 |
| CA3222905A1 (en) | 2023-01-19 |
| IT202100018740A1 (it) | 2023-01-15 |
| JP2024525794A (ja) | 2024-07-12 |
| CN119365205A (zh) | 2025-01-24 |
| MX2024000520A (es) | 2024-01-31 |
| EP4370142A1 (en) | 2024-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11701397B2 (en) | Use of L. reuteri for recovery of microbiota dysbiosis in early life | |
| CN103889238B (zh) | 用于脑生长和/或认知和/或心理运动发育的组合物 | |
| IL309883A (en) | Use of lactobacillus paracasei bacterial strains in the treatment of newborns | |
| EP2308498A1 (en) | Administration of Bifidobacterium breve during infancy to prevent inflammation later in life | |
| EP3182841B1 (en) | Prebiotics for reducing the risk of obesity later in life | |
| US11229659B2 (en) | Compositions with specific oligosaccharides to prevent or treat allergies | |
| CN101909615A (zh) | 预防和治疗病毒感染后的继发感染 | |
| CN103889239A (zh) | 用于促进肠血管生成和营养吸收和经肠喂养耐受性和/或预防和/或治疗肠炎、和/或肠损伤和手术后恢复的组合物 | |
| CN105555283B (zh) | 用于婴儿过度啼哭的益生菌 | |
| US20230270798A1 (en) | Synbiotic composition | |
| Wang et al. | Efficacy of probiotic therapy in full-term infants with critical illness | |
| AU2019407214B2 (en) | A nutritional composition comprising metabolites of HMOs to improve the gastrointestinal barrier | |
| Mshvildadze et al. | Probiotics and prevention of necrotizing enterocolitis | |
| CA3181624A1 (en) | A nutritional composition comprising 3-hydroxybutyric acid to improve the gastrointestinal barrier | |
| Chukwu et al. | Role of anaerobes as probiotic organisms | |
| JP7854400B2 (ja) | 胃腸バリアを改善するための３－ヒドロキシ酪酸を含む栄養組成物 | |
| Salvetti et al. | A survey on established and novel strains for probiotic applications | |
| Safdari et al. | An Overview of Probiotics for Prevention and Treatment | |
| TW201316983A (zh) | 用於促進腸血管新生作用及養分吸收及經腸給養耐受性、及／或預防及／或治療腸發炎、及／或腸損傷及手術後恢復之組合物 | |
| Mičetić-Turk et al. | Clinical use of probiotics in pediatrics. |